BUZZ-Tekmira Pharmaceuticals Corp: Developing Ebola drug

Mon Aug 4, 2014 8:43am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares up 7.6 pct at $15.36 premarket

** Tekmira hopes to produce first treatment for Ebola virus

** U.S. FDA says willing to work with companies testing Ebola drug; would consider special emergency new drug applications

** Earlier this month, FDA put clinical trial of Tekmira's TKM-Ebola on hold

** Tekmira's shares rose sharply on Friday on news Ebola outbreak in West Africa has intensified